Assessments of the effects of TXN expression on survival of lung cancer patients showed that TXN was associated with OS (P = 0.024, HR 1.26, 95% CI: 1.03-1.56), but its predictive power was weak (AUC 0.568, 95% CI: 0.534-0.605). Here, TXN is linked to lung carcinoma.